Bromocriptine, originally marketed as Parlodel and subsequently under many brand names, is an ergoline derivative and dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease, hyperprolactinaemia, neuroleptic malignant syndrome, and, as an adjunct, type 2 diabetes.
It was patented in 1968 and approved for medical use in 1975.
|
Read full article at Wikipedia
|
InChI=1S/C6H13O10P/c7- 2(1- 16- 17(13,14) 15) 3(8) 4(9) 5(10) 6(11) 12/h2- 5,7- 10H,1H2,(H,11,12) (H2,13,14,15) /t2- ,3- ,4+,5- /m1/s1 |
BIRSGZKFKXLSJQ-SQOUGZDYSA-N |
O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O |
|
fundamental metabolite
Any metabolite produced by all living cells.
|
|
View more via ChEBI Ontology
6-O-phosphono-D-gluconic acid
|
6-Phospho-D-gluconate
|
KEGG COMPOUND
|
1729373
|
Reaxys Registry Number
|
Reaxys
|
921-62-0
|
CAS Registry Number
|
ChemIDplus
|
15337450
|
PubMed citation
|
Europe PMC
|
4626611
|
PubMed citation
|
Europe PMC
|
|